Shares of HIMS experienced a dramatic drop today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by more than 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts specula